Showing results (1-10 of 969) with videos related to
Sort By:
Pageof 97
Rheumatic Diseases Clinics of North America|November 16, 2024
Long COVID for the Rheumatologist: Current Understanding and Approach to ManagementLeonard H Calabrese, Cassandra CalabreseCurrent Opinion in Rheumatology|January 11, 2020
The immunopathogenesis of rheumatic immune adverse events from checkpoint inhibitors: prospects for targeted therapyLeonard H Calabrese, Cassandra CalabreseCleveland Clinic Journal of Medicine|February 2, 2021
Baricitinib and dexamethasone for hospitalized patients with COVID-19Leonard H Calabrese, Cassandra CalabreseCleveland Clinic Journal of Medicine|July 11, 2020
Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1Leonard H Calabrese, Cassandra CalabreseBest Practice & Research. Clinical Rheumatology|November 11, 2022
Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implicationsCassandra Calabrese, Elizabeth Kirchner, Leonard H CalabreseCleveland Clinic Journal of Medicine|August 6, 2020
Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSFLeonard H Calabrese, Tiphaine Lenfant, Cassandra CalabreseCleveland Clinic Journal of Medicine|August 28, 2020
Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 4: The role of JAK inhibitionLeonard H Calabrese, Tiphaine Lenfant, Cassandra CalabreseCleveland Clinic Journal of Medicine|November 21, 2020
Interferon therapy for COVID-19 and emerging infections: Prospects and concernsLeonard H Calabrese, Tiphaine Lenfant, Cassandra CalabreseNature Reviews. Rheumatology|September 2, 2018
Rheumatic immune-related adverse events from cancer immunotherapyLeonard H Calabrese, Cassandra Calabrese, Laura C CappelliCleveland Clinic Journal of Medicine|July 1, 2024
Preventing herpes zoster in immunocompromised patients: Current conceptsCassandra Calabrese, Elizabeth Kirchner, James Fernandez, et al.Pageof 97